Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Axcel and Netel in connection with Netel's acquisition of Telog
Mandate

Vinge has advised Axcel and Netel in connection with Netel's acquisition of Telog

April 13, 2015

Vinge has advised Axcel and Netel in connection with Netel's acquisition of Telog Oy, where the current sellers retain a certain stake in the company. Telog Oy and its subsidiaries carry out consulting, construction, installation and maintenance within the sectors fixed telecom, mobile telecom and power grid infrastructure. Through this acquisition, Netel expands its business within these sectors in Finland and Estonia.

Vinge's team consisted of responsible partner Christina Kokko and associates Sofie Bjärtun and Johanna Wiberg, assisted by Krogerus (Finland).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025